Fluoropharma Medical Inc (FPMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,260 | -954 | -18 | -17 | -73 |
| Depreciation Amortization | 50 | 52 | 1 | 1 | 1 |
| Accounts receivable | N/A | 50 | N/A | 6 | -6 |
| Accounts payable and accrued liabilities | -318 | 57 | -2 | -3 | 5 |
| Other Working Capital | -575 | 332 | 2 | 13 | -7 |
| Other Operating Activity | 1,824 | -11 | 2 | -3 | 11 |
| Operating Cash Flow | $-2,280 | $-476 | $-15 | $-3 | $-69 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -163 | -5 | N/A | N/A | -6 |
| Purchase Sale Intangibles | -23 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -23 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-186 | $-5 | $N/A | $N/A | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 195 | 490 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 12 | 2 | 34 |
| Debt Repayment | N/A | N/A | 0 | -5 | -4 |
| Common Stock Issued | 4,130 | N/A | N/A | N/A | 50 |
| Other Financing Activity | 1,395 | 0 | 3 | 0 | 0 |
| Financing Cash Flow | $5,720 | $490 | $15 | $-4 | $81 |
| Beginning Cash Position | 11 | 2 | 0 | 7 | N/A |
| End Cash Position | 3,265 | 11 | 0 | 0 | 7 |
| Net Cash Flow | $3,254 | $10 | $0 | $-6 | $7 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,280 | -476 | -15 | -3 | -69 |
| Capital Expenditure | -163 | -5 | N/A | N/A | -6 |
| Free Cash Flow | -2,443 | -480 | -15 | -3 | -74 |